Depression Research and Treatment / 2014 / Article / Tab 3 / Clinical Study
Lovastatin as an Adjuvant to Lithium for Treating Manic Phase of Bipolar Disorder: A 4-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Table 3 The rate of adverse effects in both groups.
Lovastatin group
(%) Placebo group
(%)
value Constipation 0 1 (4.0%) — Dizziness 6 (26.1) 3 (33.3) 0.1 Hypotension 1 (4.3) 1 (4.0%) — Dry mouth 1 (4.3) 0 — Blurred vision 0 0 — Sweating 0 1 (4.0%) — Urinary disturbance 0 0 — Tremor 10 (43.5) 18 (72) 0.04 Anorexia 0 0 — Nervousness 3 (13) 9 (39.0) — Agitation 6 (30) 14 (56.0) 0.045 Headache 0 0 — Insomnia 0 0 — Diarrhea 0 0 — Nausea 10 (43.5) 14 (56.0) — Drowsiness 6 (26.1)
3 (12.0) — Rash 0 2 (8.0) — Cramps 0 0 — Myalgia 0 0 —